93 related articles for article (PubMed ID: 33785400)
21. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
Gao D; Zhang Y; Zhu M; Liu S; Wang X
PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
[TBL] [Abstract][Full Text] [Related]
22. HPV genotyping and site of viral integration in cervical cancers in Indian women.
Das P; Thomas A; Mahantshetty U; Shrivastava SK; Deodhar K; Mulherkar R
PLoS One; 2012; 7(7):e41012. PubMed ID: 22815898
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization.
Brink AA; Wiegant JC; Szuhai K; Tanke HJ; Kenter GG; Fleuren GJ; Schuuring E; Raap AK
Cancer Genet Cytogenet; 2002 Apr; 134(2):145-50. PubMed ID: 12034529
[TBL] [Abstract][Full Text] [Related]
24. Preferential expression of a HPV genotype in invasive cervical carcinomas infected by multiple genotypes.
Brant AC; Menezes AN; Felix SP; Almeida LM; Moreira MAM
Genomics; 2020 Sep; 112(5):2942-2948. PubMed ID: 32437850
[TBL] [Abstract][Full Text] [Related]
25. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of HPV-independent cervical cancers.
Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
[TBL] [Abstract][Full Text] [Related]
28. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.
Yoshinouchi M; Hongo A; Nakamura K; Kodama J; Itoh S; Sakai H; Kudo T
J Clin Microbiol; 1999 Nov; 37(11):3514-7. PubMed ID: 10523544
[TBL] [Abstract][Full Text] [Related]
29. Genomic characterization of cervical cancer based on human papillomavirus status.
Zhang L; Jiang Y; Lu X; Zhao H; Chen C; Wang Y; Hu W; Zhu Y; Yan H; Yan F
Gynecol Oncol; 2019 Mar; 152(3):629-637. PubMed ID: 30581036
[TBL] [Abstract][Full Text] [Related]
30. Identification of HPV Integration and Genomic Patterns Delineating the Clinical Landscape of Cervical Cancer.
Akeel RA
Asian Pac J Cancer Prev; 2015; 16(18):8041-5. PubMed ID: 26745036
[TBL] [Abstract][Full Text] [Related]
31. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China.
Liu HY; Zhou SL; Ku JW; Zhang DY; Li B; Han XN; Fan ZM; Cui JL; Lin HL; Guo ET; Chen X; Yuan Y; Han JJ; Zhang W; Zhang LQ; Zhou FY; Liao SX; Hong JY; Wang LD
Arch Virol; 2014 Jun; 159(6):1393-401. PubMed ID: 24385156
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
34. A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients.
Si JY; Lee K; Han R; Zhang W; Tan BB; Song GX; Liu S; Chen LF; Zhao WM; Jia LP
J Cancer Res Clin Oncol; 1991; 117(5):454-9. PubMed ID: 1653781
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus and cervical neoplasia.
Einstein MH; Goldberg GL
Cancer Invest; 2002; 20(7-8):1080-5. PubMed ID: 12449741
[TBL] [Abstract][Full Text] [Related]
36. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines.
Diao MK; Liu CY; Liu HW; Li JT; Li F; Mehryar MM; Wang YJ; Zhan SB; Zhou YB; Zhong RG; Zeng Y
Life Sci; 2015 Apr; 127():46-52. PubMed ID: 25747255
[TBL] [Abstract][Full Text] [Related]
37. Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells.
Shen C; Liu Y; Shi S; Zhang R; Zhang T; Xu Q; Zhu P; Chen X; Lu F
Int J Cancer; 2017 Aug; 141(3):540-548. PubMed ID: 28470669
[TBL] [Abstract][Full Text] [Related]
38. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
Kwon EJ; Ha M; Jang JY; Kim YH
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
[TBL] [Abstract][Full Text] [Related]
39. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.
Liang WS; Aldrich J; Nasser S; Kurdoglu A; Phillips L; Reiman R; McDonald J; Izatt T; Christoforides A; Baker A; Craig C; Egan JB; Chase DM; Farley JH; Bryce AH; Stewart AK; Borad MJ; Carpten JD; Craig DW; Monk BJ
Int J Gynecol Cancer; 2014 Feb; 24(2):329-38. PubMed ID: 24418928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
